Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have earned an average recommendation of “Hold” from the six research firms that are covering the stock, MarketBeat reports. Four equities ...

Headquartered in Mountain View, CA, Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply ...

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Omnicell (OMCL – Research Report) today. The company’s shares closed yesterday at ...

To gain a panoramic view of Omnicell's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings ...

Omnicell (NASDAQ:OMCL – Get Free Report ... XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as ...

HEAL seeks to provide investors exposure to the growing HealthTech industry, which is expected to grow fourfold from $225 ...

Pursuant to Section 9-610 of the Uniform Commercial Code, LSD Lending LLC, a Texas limited liability company (the "Secured Party") will hold a secured party public sale to the highest and best bidder ...